Skip to content

13F-HR filed by Pivotal bioVenture Partners Investment Advisor LLC

Pivotal bioVenture Partners Investment Advisor LLC filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-11, with 11 holding rows worth $303,344,814.

Accession
0001012975-23-000330
Filed
2023-08-11
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2023

A holdings report, 11 entries on the cover page, a total value of $303,344,814 stated on the cover page (in dollars after the unit check, H1), rows summing to $303,344,814 with VALUE read as dollars as filed, 13F file number 028-20630. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
KARUNA THERAPEUTICS INC48576A100COM782,008$169,578,435dollars as filed
VAXCYTE INC COM92243G108Stock793,036$39,604,218dollars as filed
OCULIS HOLDING AGH5870P102CMN2,381,196$29,360,147dollars as filed
INOZYME PHARMA INC45790W108COM3,661,518$20,394,655dollars as filed
RALLYBIO CORP75120L100COM2,404,644$13,610,285dollars as filed
ARCUTIS BIOTHERAPEUTICS INC03969K108COM1,105,309$10,533,595dollars as filed
FUSION PHARMACEUTICALS INC36118A100COM1,560,982$7,289,786dollars as filed
VIGIL NEUROSCIENCE INC92673K108COM560,595$5,269,593dollars as filed
EXSCIENTIA PLC30223G102ADS770,500$4,561,360dollars as filed
BOLT BIOTHERAPEUTICS INC097702104COM1,891,467$2,421,078dollars as filed
ALIGOS THERAPEUTICS INC COM NEW01626L105Stock743,215$721,662dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001012975-23-000330this filing2023-08-11acceptance time not in the bulk data set